Vanguard Group Inc - Sep 30, 2025 SCHEDULE 13G Report for Soleno Therapeutics Inc Common Stock (SLNO)

Filing Manager: Vanguard Group Inc
Reporting Manager: The Vanguard Group
Security: Soleno Therapeutics Inc Common Stock
Symbol: SLNO
Shares outstanding: 53.2M shares
Disclosed Ownership: 2.81M shares
Ownership: 5.28%
Form type: SCHEDULE 13G
Date filed: 10/31/2025, 11:31 AM
Date of event: Sep 30, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	5.28%	2.81M	0	324K	Ashley Grim	Head of Global Fund Administration